Stay updated on Inhibitors for COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Inhibitors for COVID-19 Clinical Trial page.

Latest updates to the Inhibitors for COVID-19 Clinical Trial page
- CheckyesterdayChange DetectedThe page no longer displays the invitation to tell ClinicalTrials.gov about a visit or the accompanying survey disclosure and OMB approval notice. The study information remains unchanged.SummaryDifference0.3%

- Check8 days agoChange DetectedThe MATIS COVID-19 trial record is now displayed, describing a completed study of ruxolitinib and fostamatinib versus standard care, along with its methods, outcomes, participating locations, and supporting documents.SummaryDifference62%

- Check15 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.2 to v3.8.0 while the study page continues to display a 403 error.SummaryDifference0.2%

- Check23 days agoChange DetectedA site-wide banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check29 days agoChange DetectedThe footer revision marker changes from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check36 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error instead of the clinical study record.SummaryDifference0.2%

Stay in the know with updates to Inhibitors for COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhibitors for COVID-19 Clinical Trial page.